HIGHLIGHTS
- who: LncRNA TNK and collaborators from the The First Affiliated Hospital of Henan University of Science and Technology have published the research work: ELK1-induced upregulation of long non-coding TNK2-AS1 promotes the progression of acute myeloid leukemia by EZH2-mediated epigenetic silencing of CELF2, in the Journal: (JOURNAL)
- what: Our results revealed that TNK2-AS1 was remarkably upregulated in AML patients and partly activated by ELK1.
- how: Tumor xenografts All animal care and experiments were carried out in accordance with the guidance of the National Institutes of Health and approved by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.